Heated yoga sessions linked to greater reductions in depressive symptoms

In a randomized controlled clinical trial of adults with moderate-to-severe depression, those who participated in heated yoga sessions experienced significantly greater reductions in depressive symptoms compared with a control group.

Cybin Initiates Dosing of Final Cohort of its Phase 2 Trial of CYB003 in Major Depressive Disorder | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN / NEO:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that

August 4, 2023

Elon Musk ‘Takes Ketamine to Manage Depression’, Report Says | Psychedelic Spotlight

The fact that executives often take psychedelics to “turn on, tune in, and drop out” is old news. Reports that the homes of Facebook, Apple,

June 29, 2023

Is this the beginning of the AI-in-drug-discovery era, or the beginning of the end?

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. This

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.